WallStreetZenWallStreetZen

NASDAQ: IPA
Immunoprecise Antibodies Ltd Stock Ownership - Who owns Immunoprecise Antibodies?

Insider buying vs selling

Have Immunoprecise Antibodies Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when IPA insiders and whales buy or sell their stock.

IPA Shareholders

What type of owners hold Immunoprecise Antibodies Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ingalls Snyder LLC4.87%1,281,305$2.01MInstitution
Citadel Advisors LLC0.29%75,031$117.80kInstitution
Northern Trust Corp0.23%60,914$95.63kInstitution
Squarepoint Ops LLC0.18%47,957$75.29kInstitution
Bank Of Montreal0.18%47,521$74.61kInstitution
Cibc World Market Inc0.16%41,200$64.68kInstitution
Gradient Capital Advisors LLC0.10%26,808$42.09kInstitution
Renaissance Technologies LLC0.09%23,000$36.11kInstitution
Millennium Management LLC0.07%19,011$29.85kInstitution
Geode Capital Management LLC0.07%17,484$27.45kInstitution

1 of 3

IPA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IPA6.56%0.00%
VIRX3.63%96.37%Net BuyingNet Selling
NRXP4.75%71.56%Net Buying
ICCC13.45%24.31%Net Buying
NKGN15.84%84.16%Net Buying

Immunoprecise Antibodies Stock Ownership FAQ

Who owns Immunoprecise Antibodies?

Immunoprecise Antibodies (NASDAQ: IPA) is owned by 6.56% institutional shareholders, 0.00% Immunoprecise Antibodies insiders, and 93.44% retail investors. Ingalls Snyder LLC is the largest individual Immunoprecise Antibodies shareholder, owning 1.28M shares representing 4.87% of the company. Ingalls Snyder LLC's Immunoprecise Antibodies shares are currently valued at $1.95M.

If you're new to stock investing, here's how to buy Immunoprecise Antibodies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.